OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive ...
BXQ-350 efficacy and safety evaluation in first line mCRC patients: A phase 1b/2 study of BXQ-350, a first-in-class sphingolipid metabolism modulator, in combination with mFOLFOX7 plus bevacizumab in ...
An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
A Cell Perspective argues that generative AI models could help tackle cancer’s multiscale, multimodal complexity by ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
Lung cancer remains the leading cause of cancer-related deaths worldwide, accounting for nearly one in five cancer deaths—around 1.8 million lives lost each year. One of the main reasons is late ...
Multicancer early detection (MCED) assays use circulating tumor DNA, methylation patterns, RNA, and protein biomarkers to detect multiple cancer types early, potentially revolutionizing cancer ...
MethylScan is a low-cost blood test that detects cancers and organ diseases by analyzing DNA methylation, improving early diagnosis, and identifying disease origin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results